Federal Circuit Affirms PTO Finding that Claims of Morsa Patent Application are Anticipated by Press Release Reference

Oct 21, 2015

Reading Time : 1 min

The pertinent claims of the ’228 Application are directed to a benefit information match mechanism. In comparing the claims of the ’228 Application to the prior art reference, the court found that each of the four limitations map directly to the reference. The court further found the specification of the ’228 Application disclosed that a skilled artisan at the time would have understood how to use central processing units and memories to process requests for benefit information, and that the system claimed in the patent could be implemented by any programmer of ordinary skill using commercially available tools. Because the reference disclosed the claim limitations and the specification indicated that one of ordinary skill would be capable of programming the invention, the court held the board correctly concluded the reference was enabling.

Chief Judge Prost wrote for a majority of the panel. Judge Newman issued a dissenting opinion in which she challenged the determinations of the majority as confusing “the laws of anticipation and obviousness and the role of enablement as applied to prior art references.” In particular, Judge Newman stated that it was improper for the board to take “Official Notice” of matter not disclosed in the prior art and equally improper for the majority to fill the gaps in the Board’s decision by relying on disclosures in the ’228 Application. 

In re: Steve Morsa, Case No. 2015-1107 (Fed. Cir. Oct. 19, 2015).

Share This Insight

Categories

Previous Entries

IP Newsflash

July 22, 2026

The Court of Federal Claims recently denied the United States’ motion to dismiss a patent infringement suit related to production of a COVID-19 vaccine. The court held that it had jurisdiction because the plaintiff filed its claim there before it filed a parallel suit in a district court and because it adequately pleaded the government’s involvement.

...

Read More

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.